Guidance for Industry Regulatory Classification of Pharmaceutical Co-Crystals

First Page		Document Content
Dosage forms Crystallography Chemical engineering Pharmaceutical industry Polymorphism Active ingredient Cocrystal Tablet Crystallization Chemistry Pharmaceutical sciences Pharmacology		Guidance for Industry Regulatory Classification of Pharmaceutical Co-Crystals Add to Reading List Source URL: www.fda.gov Download Document from Source Website File Size: 83,89 KB Share Document on Facebook

	------------------------DOSAGE FORMS AND STRENGTHS------------------Suspension for oral administration supplied as a packet of the buffer component and a packet of the active component (lyophilized V. cholerae CVD 103-Hg DocID: 1uayH - View Document
	zanaflex rebates zanaflex medication. zanaflex dose zanaflex canadian zanaflex withdrawel. zanaflex warning. side effect of zanaflex zanaflex tachyphylaxis buy name brand zanaflex. zanaflex dosage forms DocID: 1sJyv - View Document
	----------------------DOSAGE FORMS AND STRENGTHS--------------------- HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use DARZALEX™ safely and effectively. See full DocID: 1smxh - View Document
	Soothing After Shave Lotion with Neossance Squalane.pub DocID: 1rsnF - View Document
	Figure A Gray Scale Actuator_cap_mouthpiece_PMS186_K_v2.tif DocID: 1rqp5 - View Document